UNLABELLED: We evaluated the predictive ability of FRAX® in a cohort of 815 Japanese women. The observed 10-year fracture rate did not differ significantly from that predicted by FRAX®. The predictive ability of FRAX® without femoral neck bone mineral density (BMD) was similar to that with femoral neck BMD. INTRODUCTION: We evaluated the ability of the Japanese version of FRAX®, a World Health Organization fracture risk assessment tool, to predict the 10-year probability of osteoporotic fracture. METHODS: Self-reported major osteoporotic fracture (N = 43) and hip fracture (N = 4) events were ascertained in the 10-year follow-up survey of the Japanese Population-Based Osteoporosis Cohort Study. Participants were 815 women aged 40-74 years at the baseline survey. Receiver operating characteristic curve analysis compared FRAX® with multiple logistic models based on age, body weight, and femoral neck BMD. RESULTS: The number of observed major osteoporotic or hip fracture events did not differ significantly from the number of events predicted by the FRAX® model (with or without BMD). The area under the curve (AUC) value for FRAX® with BMD for predicting major osteoporotic fractures was similar to that of a logistic model with age, body weight, and BMD (0.69 vs. 0.71, respectively; p = 0.198); the AUC of FRAX® with BMD for predicting hip fractures was similar to that of a model based on age and BMD (0.88 vs. 0.89, respectively; p = 0.164). The AUCs of FRAX® without BMD for predicting major osteoporotic and hip fractures were similar to those with BMD (0.69 vs. 0.67, respectively; p = 0.121; 0.88 vs. 0.86, respectively; p = 0.445). CONCLUSIONS: The Japanese version of FRAX® without BMD estimated the 10-year probability of osteoporotic fracture in this population with few clinical risk factors as similar to that of FRAX® with BMD.
UNLABELLED: We evaluated the predictive ability of FRAX® in a cohort of 815 Japanese women. The observed 10-year fracture rate did not differ significantly from that predicted by FRAX®. The predictive ability of FRAX® without femoral neck bone mineral density (BMD) was similar to that with femoral neck BMD. INTRODUCTION: We evaluated the ability of the Japanese version of FRAX®, a World Health Organization fracture risk assessment tool, to predict the 10-year probability of osteoporotic fracture. METHODS: Self-reported major osteoporotic fracture (N = 43) and hip fracture (N = 4) events were ascertained in the 10-year follow-up survey of the Japanese Population-Based Osteoporosis Cohort Study. Participants were 815 women aged 40-74 years at the baseline survey. Receiver operating characteristic curve analysis compared FRAX® with multiple logistic models based on age, body weight, and femoral neck BMD. RESULTS: The number of observed major osteoporotic or hip fracture events did not differ significantly from the number of events predicted by the FRAX® model (with or without BMD). The area under the curve (AUC) value for FRAX® with BMD for predicting major osteoporotic fractures was similar to that of a logistic model with age, body weight, and BMD (0.69 vs. 0.71, respectively; p = 0.198); the AUC of FRAX® with BMD for predicting hip fractures was similar to that of a model based on age and BMD (0.88 vs. 0.89, respectively; p = 0.164). The AUCs of FRAX® without BMD for predicting major osteoporotic and hip fractures were similar to those with BMD (0.69 vs. 0.67, respectively; p = 0.121; 0.88 vs. 0.86, respectively; p = 0.445). CONCLUSIONS: The Japanese version of FRAX® without BMD estimated the 10-year probability of osteoporotic fracture in this population with few clinical risk factors as similar to that of FRAX® with BMD.
Authors: M Iki; A Morita; Y Ikeda; Y Sato; T Akiba; T Matsumoto; H Nishino; S Kagamimori; Y Kagawa; H Yoneshima Journal: Osteoporos Int Date: 2006-05-03 Impact factor: 4.507
Authors: A A Ismail; T W O'Neill; W Cockerill; J D Finn; J B Cannata; K Hoszowski; O Johnell; C Matthis; H Raspe; A Raspe; J Reeve; A J Silman Journal: Osteoporos Int Date: 2000 Impact factor: 4.507
Authors: E V McCloskey; T D Spector; K S Eyres; E D Fern; N O'Rourke; S Vasikaran; J A Kanis Journal: Osteoporos Int Date: 1993-05 Impact factor: 4.507
Authors: S Fujiwara; T Nakamura; H Orimo; T Hosoi; I Gorai; A Oden; H Johansson; J A Kanis Journal: Osteoporos Int Date: 2008-02-22 Impact factor: 4.507
Authors: L Joseph Melton; Elizabeth J Atkinson; Sara J Achenbach; John A Kanis; Terry M Therneau; Helena Johansson; Sundeep Khosla; Shreyasee Amin Journal: J Osteoporos Date: 2012-08-15
Authors: Hana Kim; Jung Hee Kim; Min Joo Kim; A Ram Hong; HyungJin Choi; EuJeong Ku; Ji Hyun Lee; Chan Soo Shin; Nam H Cho Journal: Endocrinol Metab (Seoul) Date: 2020-06-24
Authors: Ralph Kwame Akyea; Tricia M McKeever; Jack Gibson; Jane E Scullion; Charlotte E Bolton Journal: BMJ Open Date: 2019-04-03 Impact factor: 2.692
Authors: Andréa Marques; Raquel Lucas; Eugénia Simões; Suzanne M M Verstappen; Johannes W G Jacobs; Jose A P da Silva Journal: RMD Open Date: 2017-09-26